Pandemic forces Proteus into bankruptcy - MassDevice

Proteus Digital Healthproteus-digital-health has filed for Chapter 11 bankruptcy protection, noting that its efforts to raise money or sell the company fell victim to the COVID-19 pandemic.

The Redwood City, Calif.-based company missed a $100 million funding target in December. Once valued at $1.5 billion, Proteus previously raised $420 million from investors including Novartis Venture Fund and Kaiser Permanente Ventures, according to an April report by Forbes.

Proteus’ products combine oral medications with an ingestible sensor. The sensor-embedded pill was approved by the FDA in November 2017. Otsuka Pharmaceutical (TYO:4578) and Proteus developed the Abilify MyCite pill to treat schizophrenia, manic and mixed episodes linked with bipolar I disorder and depression in adults. Otsuka and Proteus signed an $88 million deal in 2018 in which Proteus would help Otsuka develop more digital medicines while commercializing the smart pill technology.

The first cancer patients were treated using its digital oncology therapy in January 2019. At the time, company had also launched a digital oral oncolytic medication registry to gather real-world data from cancer patients using digital medicines.

In January of this year, Proteus announced a multi-year, outcomes-based deal with the state of Tennessee’s Medicaid program, TennCare, to support TennCare-covered patients undergoing hepatitis C treatment with medication adherence and stronger connections to their care teams.

“Filing for bankruptcy protection allows Proteus to continue its sales process in a more concerted and efficient manner while continuing to run the business as usual,” the company said in an email to MassDevice.

Corporations that file for Chapter 11 bankruptcy protection are not necessarily quitting the business. The protection from creditors is designed to allow them to restructure and regain their financial footing.

The bankruptcy filing in U.S. District Court in Delaware lists 20 creditors, most of whom Proteus owe less than $500,000. They include Romaco North America, a global supplier of pharmaceutical tableting and packaging technologies ($510,848); Otsuka ($397,721); drug manufacturer Xcelience ($215,616); investment bank B. Riley FBR ($98,789); and Robert Bosch North America ($50,000).

In the filing, Proteus said it and its advisors “commenced a robust marketing process to secure additional funding or bids for a sale of the Debtor’s business. Despite having several promising opportunities, the onset of the COVID-19 pandemic created significant uncertainty in the capital markets and frustrated the Debtor’s efforts. However, the Debtor has had fruitful discussions with Otsuka and other interested parties regarding a potential sale transaction.”

The company said it anticipates that it will seek approval of bidding and sale procedures in the early weeks of the bankruptcy case, according to the filing. It employs 93.






RSS From Medical Design & Outsourcing

  • Mass General researchers tout low-cost, portable brain imaging scanner
    Researchers at Massachusetts General Hospital are touting a low-cost, portable “head only” MRI scanner that could be used in multiple settings. As opposed to standard costly, immobile MRI scanners that require special infrastructure, the MGH researchers developed a low-cost, compact, portable and low-power scanner that could be mounted in an ambulance, wheeled into a patient’s… […]
  • HHS confirms involvement in presidential transition process
    U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential… […]
  • Swiss scientists make ‘micromachines’ for self-deploying stents and more
    Researchers in Zurich reported today that they have invented a manufacturing technique to build “micromachines” out of metal and plastic in which these two materials are interlocked as closely as links in a chain. These robots are so tiny that they can maneuver through blood vessels and deliver medications to certain points in the body… […]
  • This AI algorithm could detect COVID-19 in chest X-rays
    Northwestern University researchers are touting a new AI platform that can detect COVID-19 in X-ray images of the lungs. DeepCOVID-XR, a machine-learning algorithm, performed better than a team of specialized thoracic radiologists by spotting COVID-19 in X-rays about 10 times faster and 1%-6% more accurately, according to a news release. Researchers involved think physicians could… […]
  • Aspen Surgical acquires Protek Medical Products
    Disposable products maker Aspen Surgical Products today announced the acquisition of Protek Medical Products (Coralville, Iowa). Protek manufactures single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration, and vascular access procedures as well as protective covers for medical instruments and equipment. The acquisition of Protek strengthens Aspen’s portfolio of medical, patient… […]
  • Puritan Medical lands $11.6M to boost swab production
    Puritan Medical Products (Guilford, Maine) has been awarded $11.6 million to expand its COVID-19 testing swab production by 3 million swabs per month, according to U.S. Sen. Susan Collins (R-Maine). The award was funded through the Paycheck Protection Program and Health Care Enhancement Act enacted in April. It will help fund modifications to Puritan’s newest… […]
  • PTI Engineered Plastics wins ‘best workplace’ award
    PTI Engineered Plastics has been awarded a Top Workplaces 2020 honor by The Detroit Free Press. The list is based solely on employee feedback gathered through a third-party survey administered by research partner Energage, according to the Macomb, Mich.-based company. An anonymous employee survey measured 15 drivers of engaged workplace cultures, including alignment, execution, and… […]
  • SyBridge enters medtech market with acquisition of X-Cell Tool & Mold
    SyBridge Technologies announced that it has completed the acquisition of X-Cell Tool & Mold, marking its first acquisition in the medical tooling industry. Fairview, Pa.-based X-Cell manufactures close-tolerance and multi-cavity plastic injection molds primarily for the medical industry. Its acquisition expands SyBridge’s tooling capabilities to include highly complex precision tooling solutions necessary for medical devices.… […]
  • Why making a lot of ventilators may not be enough to prevent COVID-19 deaths
    Medical device companies and even manufacturers outside the industry answered the call to make ventilators needed to treat people with severe COVID-19 cases. But as a newer and larger wave of the novel coronavirus hits the U.S., the equipment may not be enough, The New York Times reported yesterday. The problem, according to the Times,… […]
  • Demand, flexible financing fuel strong Mako sales for Stryker
    Stryker’s (NYSE:SYK) Mako surgical system remains a strong seller, even as hospitals grapple with pandemic-induced cuts to revenue. The orthopedics giant announced the placement of its 1,000th system in September. Those results stem not only from demand but also from financing options Stryker has extended to some hospitals, according to Spencer Stiles, group president of the… […]
  • MedTech Europe gives proposed European Health Union a partial nod
    MedTech Europe has endorsed a new plan to strengthen the EU’s response to future pandemics and public health emergencies, with a few caveats. European Commission President Ursula von der Leyen outlined the plan to create a European Health Union in her state of the union speech on Nov. 11. The plan is a response to… […]